Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders
Insulin resistance and other risk factors for atherosclerosis, such as hypertension and hypercholesterolemia, promote endothelial dysfunction and lead to development of metabolic syndrome which constitutes an introduction to cardiovascular disease. The insulin resistance and endothelial dysfunction...
Saved in:
Main Authors: | A. Janus, E. Szahidewicz-Krupska, G. Mazur, A. Doroszko |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/3634948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential therapeutic effects of SIRT1 targeting APOE4-induced microvascular endothelial dysfunction
by: Yorito Hattori, et al.
Published: (2025-03-01) -
Osteoprotegerin in Cardiometabolic Disorders
by: C. Pérez de Ciriza, et al.
Published: (2015-01-01) -
Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
by: Arpeeta Sharma, et al.
Published: (2012-01-01) -
Posttraumatic Stress Disorder Is Associated With Endothelial Dysfunction in Women With HIV
by: Nishant Vatsa, MD, et al.
Published: (2025-02-01) -
Immune and Inflammatory Processes in Obesity, Insulin Resistance, Diabetes, and Related Cardiometabolic Complications
by: Joseph Fomusi Ndisang, et al.
Published: (2014-01-01)